Cargando…
Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia
BACKGROUND: Despite their huge epidemiological impact, primary headaches, trigeminal neuralgia and other chronic pain conditions still receive suboptimal medical approach, even in developed countries. The limited efficacy of current pain-killers and prophylactic treatments stands among the main reas...
Autores principales: | Sandrini, Giorgio, De Icco, Roberto, Tassorelli, Cristina, Smania, Nicola, Tamburin, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360746/ https://www.ncbi.nlm.nih.gov/pubmed/28324318 http://dx.doi.org/10.1186/s10194-017-0744-z |
Ejemplares similares
-
Electrical Stimulation of Injected Muscles to Boost Botulinum Toxin Effect on Spasticity: Rationale, Systematic Review and State of the Art
por: Picelli, Alessandro, et al.
Publicado: (2021) -
Non-invasive Brain and Spinal Stimulation for Pain and Related Symptoms in Multiple Sclerosis: A Systematic Review
por: Zucchella, Chiara, et al.
Publicado: (2020) -
IncobotulinumtoxinA Injection for Treating Children with Idiopathic Toe Walking: A Retrospective Efficacy and Safety Study
por: Filippetti, Mirko, et al.
Publicado: (2022) -
The burden of chronic pain and the role of neurorehabilitation: consensus matters where evidence is lacking
por: Tamburin, Stefano, et al.
Publicado: (2017) -
OnabotulinumtoxinA Reduces Temporal Pain Processing at Spinal Level in Patients with Lower Limb Spasticity
por: De Icco, Roberto, et al.
Publicado: (2019)